Homeopathic trial for COVID-19 principally approved by Delhi’s AAP Government

AAP Government told the Delhi High Court on Thursday that they have principally approved the proposal provided by two homeopathic doctors for clinical trial of a certain combination of homeo medicines for prevention and cure of COVID-19.

Approval is subject to adherence to AYUSH Ministry Guidelines, Delhi govt. told to the bench of justices Hima Kohli & Subramonium Prasad.

Dr. Ravi M Nair from Kerala & Dr. Asok Kumar Das from West Bengal made this plea to allow and support conducting of clinical trial on Arsenicum album-Phosphorous-Tuberculinum (APT) combination of homeopathic medicines to prevent COVID-19.

The plea requests that doctors to be allowed to dispense homeopathic medicines as supplement to allopathic ones, if so desired by the patients.

AAP government told the court that “there shall be no financial implication of this on the Directorate of AYUSH, Government of National Capital Territory of Delhi as funding was to be provided by the Ministry of AYUSH, Government of India under an extra mural research scheme”.

The Delhi government, in its status report filed through additional standing counsel Jawahar Raja, told the court that the approval was communicated to the petitioners on July 17.

Government also informed the bench that in May it has set up a five-member advisory committee to examine and suggest steps of homeopathic system of medicine for boosting immunity against COVID-19 infection.

Pursuant to recommendations of the committee, the Delhi government has started its own study titled, ”A Pragmatic, Placebo-controlled, Parallel Groups, Randomised Clinical Trial to Assess the Efficacy of Homoeopathic Medicine(s) in the Prevention of COVID-19 in a High Risk/Exposed Population”, the report has said.

 With the sample size of 15,000 persons, its outcome would come after it is completed under the supervision of the  State Advisory Committee constituted by Delhi government.

Further hearing for this matter will be in December.

Court has asked the Delhi government why it was not writing to the CCRH for carrying out clinical trials of homoeopathic medicines for prevention and cure of COVID-19 despite requests from the two doctors.

CCRH informed the doctors that the state governments have to approach it for clinical trials and it cannot go to the states, mentioned by the doctors in their plea.

Subsequently, they wrote to the Delhi government in June itself to approach CCRH for clinical trials, however, no steps were taken by it, they have claimed.

Note: We at The Homeopath take our ethics very seriously. More information about it can be found at Disclaimer page of our website.